Interleukin-10 and liver diseases

Acta Gastro-Enterologica Belgica

Volumn 62, Issue 1, 1999, Pages 1-8

  Le Moine, Olivier ^a,b   Louis, Hubert ^a,b   Sermon, Filip ^a,b   Goldman, Michel ^a,b   Devière, Jacques ^a,b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR STIMULATING AGENT; ALPHA INTERFERON; ALPHA INTERMEDIN; CHLORPROMAZINE; CYCLOSPORIN A; DANTROLENE; DEFEROXAMINE; EBSELEN; GADOLINIUM CHLORIDE; GAMMA INTERFERON; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTAMINE; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MAXADILAN; MESSENGER RNA; PYRROLIDINE DITHIOCARBAMATE; RECOMBINANT INTERLEUKIN 10; ROQUINIMEX; THALIDOMIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TYRPHOSTIN; UNINDEXED DRUG; UROCANIC ACID;

ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE HEPATITIS; CYTOKINE PRODUCTION; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KUPFFER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER INJURY; LIVER PROTECTION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

HUMANS; INTERLEUKIN-10; LIVER; LIVER DISEASES;

EID: 0032941115     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (131)

1. FLEMING S.D., CAMPBELL P.A. Macrophages have cell surface IL-10 that regulates macrophage bactericidal activity. J. Immunol., 1996, 156 : 1143-1150.
2. CHEN W.F., ZLOTNIK A. IL-10. a novel cytotoxic T cell differentiation factor. J. Immunol., 1991, 147 : 528-534.
3. JINQUAN T., LARSEN C.G., GESSER B., MATSUSHIMA K., THESTRUP PEDERSEN K. Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration. J. Immunol., 1993, 151 : 4545-4551.
4. CARSON W.E., LINDEMANN M.J., BAIOCCHI R., LINETT M., TAN JC., CHOU CC., NARULA S., CALIGIURI M.A. The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood, 1995, 85 : 3577-3585.
5. ROUSSET F., GARCIA E., DEFRANCE T., PERONNE C., VEZZIO N., HSU H., KASTELEIN R., MOORE K.W., BANCHEREAU J. Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci., 1992, 89 : 1890-1893.
6. TE VELDE A.A., DE WAAL MALEFYT R., HUIJBENS R.J., DE VRIES J.E., FIGDOR C.G. IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4 and IL-10. J. Immunol., 1992, 149 : 4048-4052.
7. DOHERTY T.M., SEDER R.A., SHER A. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol., 1996, 156 : 735-741.
8. DENIS M., GHADIRIAN E. IL-10 neutralization augments mouse resistance to systemic mycobacterium avium infections. J. Immunol., 1993, 151 : 5425-5430.
9. GREENBERGER M.J., STRIETER RM., KUNKEL S.L., DANFORTH J.M., GOODMAN R.E., STANDIFORD T.J. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol., 1995, 155 : 722-729.
10. LEE MS., MUELLER R., WICKER LS., PETERSON LB., SARVETNICK N. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J. Exp. Med., 1996, 183 : 2663-2668.
11. LLORENTE L., ZOU W., LEVY Y., RICHAUD-PATIN Y., WIDJENES J., ALCOCER VARELA J., MOREL-FOURRIER B., BROUET JC., ALARCON-SEGOVIA D., PIERRE G., EMILIE D. Role of interleukin-10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med., 1995, 181 : 839-844.
12. MARCHANT A., DEVIÈRE J., BYL B., DE GROOTE D., VINCENT J.L., GOLDMAN M. Interleukin-10 production during septicaemia. Lancet, 1994, 343 : 707-708.
13. FONG Y.M., MARANO M.A., MOLDAWER L.L., WEI H., CALVANO S.E., KENNEY JS., ALLISON A.C., CERAMI A., SHIRES G.T., LOWRY S.F. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J. Clin. Invest., 1990, 85 : 1896-1904.
14. WAGNER R.D., CZUPRYNSKI C.J. Cytokine mRNA expression in livers of mice infected with Listeria monocytogenes. J. Leukoc. Biol., 1993, 53 : 525-531.
15. BISHOP G.A., ROKAHR K.L., NAPOLI J., MC CAUGHAN G.W. Intragraft cytokine mRNA levels in human liver allograft rejection analysed by reverse transcription and semiquantitative polymerase chain reaction amplification. Transpl. Immunol., 1993, 1 : 253-261.
16. LE MOINE O., MARCHANT A., DURAND F, ICKX B., PRADIER O., BELGHITI J., ABRAMOWICZ D., GELIN M., GOLDMAN M., DEVIERE J. Systemic release of interleukin-10 during orthotopic liver transplantation. Hepatology, 1994, 20 : 889-892.
17. RAI R.M., LOFFREDA S., KARP C.L., YANG S.Q., LIN H.Z., DIEHL A.M. Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver. Hepatology, 1997, 25 : 889-895.
18. RAI R.M., ZHANG J.X., CLEMENS M.G., DIEHL A.M. Gadolinium chloride alters the acinar distribution of phagocytosis and balance between pro- and anti-inflammatory cytokines. Shock, 1996, 6 : 243-247.
19. LOUIS H., LE MOINE O., PENY M.O., GULBIS B., NISOL F., GOLDMAN M., DEVIERE J. Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury. Gastroenterology, 1997, 112 : 935-942.
20. VAN LAETHEM J.L., ESKINAZI R., LOUIS H., RICKAERT F., ROBBERECHT P., DEVIERE J. Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut, 1998, 43 : 408-413.
21. LE MOINE O., STORDEUR P., SCHANDENÉ L., MARCHANT A., DE GROOTE D., GOLDMAN M., DEVIÈRE J. Adenosine enhances IL-10 secretion by human monocytes. J. Immunol., 1996, 156 : 4408-4414.
22. LE MOINE O., LOUIS H., STORDEUR P., COLLET J.M., GOLDMAN M., DEVIERE J. Role of reactive oxygen intermediates in interleukin 10 release after cold liver ischemia and reperfusion in mice. Gastroenterology, 1997, 113 : 1701-1706.
23. ARAI T., HIROMATSU K., KOBAYASHI N., TAKANO M., ISHIDA H., NIMURA Y., YOSHIKAI Y. IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury. J. Immunol., 1995, 155 : 5743-5749.
24. GAZZINELLI R.T., WYSOCKA M., HIENY S., SCHARTON-KERSTEN T., CHEEVER A., KÜHN R., MÜLLER W., TRINCHIERI G., SHER A. In the absence of endogenous IL-10, mice acutely infected with toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α. J. Immunol., 1996, 157 : 798-805.
25. LOUIS H., LE MOINE O., PENY MO., QUERTINMONT E., FOKAN D., GOLDMAN M., DEVIERE J. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology, 1997, 25 : 1382-1389.
26. LOUIS H., VAN LAETHEM J.L., WU W., QUERTINMONT E., DEGRAEF C, VAN DEN BERG K., DEMOLS A., GOLDMAN M., LE MOINE O., GEERTS A., DEVIERE J. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology, 1998, 28 : 1607-1615.
27. YANG S.Q., LIN H.Z., LANE M.D., CLEMENS M., DIEHL A.M. Obesity increases sensitivity to endotoxin liver injury, implications for the pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. USA, 1997, 94 : 2557-2562.
28. AKERMAN P., COTE P., YANG SQ., MC CLAIN C., NELSON S., BAGBY G.J., DIEHL A.M. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am. J. Physiol., 1992, 263 : G579-85.
29. CRESSMAN D.E., GREENBAUM L.E., DEANGELIS R.A., CILIBERTO G., FURTH E.E., POLI V., TAUB R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science, 1996, 274 : 1379-1383.
30. YAMADA Y., KIRILLOVA I., PESCHON J.J., FAUSTO N. Initiation of liver growth by tumor necrosis factor : deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. USA, 1997, 94 : 1441-1446.
31. Bedossa P., Paradis V. Transforming growth factor-beta (TGF-beta): a key-role in liver fibrogenesis. J. Hepatol., 1995, 22 : 37-42.
32. Houck KA., Michalopoulos GK. Altered responses of regenerating hepatocytes to norepinephrine and transforming growth factor type beta. J. Cell. Physiol., 1989, 141 : 503-509.
33. WANG S.C., OHATA M., SCHRUM L., RIPPE R.A., TSUKAMOTO H. Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J. Biol. Chem., 1998, 273 : 302-308.
34. SEITZ M., LOETSCHER P., DEWALD B., TOWBIN H., GALLATI H., BAGGIOLINI M. Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur. J. Immunol., 1995, 25 : 1129-1132.
35. REITAMO S., REMITZ A., TAMAI K., UITTO J. Interleukin-10 modulates type-1 collagen and matrix metalloprotease gene expressionin cultured human skin fibroblasts. J. Clin. Invest., 1994, 94 : 2489-2492.
36. THOMPSON K.C., TROWERN A., FOWELL A., MARATHE M., HAYCOCK C., ARTHUR MJP., SHERON N. Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin-10 during the course of activation In vitro [In Process Citation]. Hepatology, 1998, 28 : 1518-1524.
37. THOMPSON K., MALTBY J., FALLOWFIELD J., MCAULAY M., MILLWARD-SADLER H., SHERON N. Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis [In Process Citation]. Hepatology, 1998, 28 : 1597-1606.
38. MC CLAIN C.J., COHEN D.A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology, 1989, 9 : 349-351.
39. DEVIÈRE J., CONTENT J., DENYS C., VANDENBUSSCHE P., SCHANDENÉ L., WYBRAN J., DUPONT E. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in alcoholic cirrhosis. Hepatology, 1990, 11 : 628-634.
40. LE MOINE O., MARCHANT A., DE GROOTE D., AZAR C., GOLDMAN M., DEVIERE J. Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis. Hepatology, 1995, 22 : 1436-1439.
41. LLORENT L., RICHAUD-PATIN Y., ALCOCER-CASTILLEJOS N., RUIZ-SOTO R., MERCADO M.A., OROZCO H., GAMBOA-DOMINGUEZ A., ALCOCER-VARELA J. Cytokine gene expression in cirrhotic and non-cirrhotic human liver. J. Hepatol., 1996, 24 : 555-563.
42. NAPOLI J., BISHOP G.A., MCGUINNESS P.H., PAINTER D.M., MC CAUGHAN G.W. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology, 1996, 24 : 759-765.
43. YAMASHIKI M., NISHIMURA A., SUZUKI H., SAKAGUCHI S., KOSAKA Y. Effects of the Japanese herbal medicine "Sho-saiko-to" (TJ-9) on in vitro interleukin-10 production by peripheral blood mononuclear cells of patients with chronic hepatitis C Hepatology, 1997, 25 : 1390-1397.
44. CONTI F., BOULLAND M.L., LEROY-VIARD K., CHEREAU C., DOUSSET B., SOUBRANE O., WEILL B., CALMUS Y. Low level of interleukin 10 synthesis during liver allograft rejection. Lab. Invest., 1998, 78 : 1281-1289.
45. LOHR H.F., SCHLAAK J.F., GERKEN G., FLEISCHER B., DIENES H.P., MEYER ZUM BUSCHENFELDE K.H. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver, 1994, 14 : 161-166.
46. SANTUCCI L., FIORUCCI S., CHIOREAN M., BRUNORI P.M., DI MATTEO F.M., SIDONI A., MIGLIORATI G., MORELLI A. Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology, 1996, 111 : 736-744.
47. TIEGS G., HENTSCHEL J., WENDEL A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest., 1992, 90 : 196-203.
48. LE MOINE O., LOUIS H., QUERTINMONT E., NARULA S., GOLDMAN M., DEVIÈRE J. Donor pretreatment with IL-10 decreases TNF, IFN-gamma release and liver injury after cold ischemia-reperfusion in mice. Gastroenterology, 1998, 113 : A(Abstract)
49. LE MOINE O., DEVIÈRE J., GOLDMAN M. The inflammatory cascade of liver ischemia and reperfusion, from the donor to the recipient. In : TOURAINE J.L., et al. (eds). Organ allocation. Kluwer Academic Publishers, 1998., pp 181-208.
50. LOHSE A.W., KNOLLE P.A., BILO K., UHRIG A., WALDMANN C., IBE M., SCHMITT E., GERKEN G., MEYER ZUM BUSCHENFELDE K.H. Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology, 1996, 110 : 1175-1181.
51. KNOLLE P.A., UHRIG A., HEGENBARTH S., LOSER E., SCHMITT E., GERKEN G., LOHSE A.W. IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal encothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin. Exp. Immunol., 1998, 114 : 427-433.
52. ESTAQUIER J., AMEISEN J.C. A role for T-helper type-1 and type-2 cytokines in the regulation of human monocyte apoptosis. Blood, 1997, 90 : 1618-1625.
53. COX G. IL-10 enhances resolution of pulmonary inflammation in vivo by promoting apoptosis of neutrophils. Am. J. Physiol., 1996, 271 : L566-71.
54. CHERNOFF A.E., GRANOWITZ E.V., SHAPIRO L., VANNIER L., LONNEMANN G., ANGEL J.B., KENNEDY J.S., RABSON A.R., WOLFF SM., DINARELLO C.A. A randomized., controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J. Immunol., 1995, 154 : 5492-5499.
55. PAJKRT D., CAMOGLIO L., TIEL VAN BUUL M.C., DE BRUIN K., CUTLER D.L., AFFRIME M.B., RIKKEN G., VAN DER POLL T., TEN CATE J.W., VAN DEVENTER S.J. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia. effect of timing of recombinant human IL-10 administration. J. Immunol., 1997, 158 : 3971-3977.
56. RADWANSKI E., CHAKRABORTY A., VAN WART S., HUHN R.D., CUTLER D.L., AFFRIME M.B., JUSKO W.J. Pharmacokinetics and leukocyte responses of recombinant human interleukin-10 [In Process Citation]. Pharm. Res., 1998, 15 : 1895-1901.
57. VAN DEVENTER S.J., ELSON C.O., FEDORAK R.N. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology, 1997, 113 : 383-389.
58. KEYSTONE E., WHERRY J., GRINT P. IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. Rheum. Dis. Clin. North Am., 1998, 24 : 629-639.
59. ASADULLAH K., STERRY W., STEPHANEK K., JASULAITIS D., LEUPOLD M., AUDRING H., VOLK H.D., DOCKE W.D. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy. a new therapeutic approach. J. Clin. Invest., 1998, 101 : 783-794.
60. WISSING KM., MORELON E., LEGENDRE C., DE PAUW L., LEBEAUT A., GRINT P., MANISCALKI M., ICKX B., VEREERSTRAETEN P., CHATENOUD L., KREIS H., GOLDMAN M., ABRAMOWICZ D. A pilot trial of recombinant human interleukin-10 in kidney transplant recipients receiving OKT3 induction therapy. Transplantation, 1997, 64 : 999-1006.
61. JOYCE D.A., GIBBONS D.P., GREEN P., STEER J.H., FELDMANN M., BRENNAN F.M. Two inhibitors of pro-inflammatory cytokine release., interleukin-10 and interleukin-4., have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur. J. Immunol., 1994, 24 : 2699-2705.
62. MOORE K.W., O'GARRA A., DE WAAL MALEFYT R., VIEIRA P., MOSMANN T.R. Interleukin-10. Annu Rev. Immunol., 1993, 11 : 165-190.
63. CASSATELLA M.A., MEDA L., BONORA S., CESKA M., CONSTANTIN G. Interleukin-10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-beta in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med., 1993, 178 : 2207-2211.
64. KASAMA T., STRIETER R.M., LUKACS N.W., BURDICK M.D., KUNKEL S.L. Regulation of neutrophil-derived chemokine expression by IL-10. J. Immunol., 1994, 152 : 3559-3569.
65. TAKANASKI S., NONAKA R., XING Z., O'BYRNE P., DOLOVICH J., JORDANA M. Interleukin-10 inhibits lipopolysaccharide induced survival and cytokine production by human peripheral blood eosinophils. J. Exp. Med., 1994, 180 : 711-715.
66. NAKAJIMA H., GLEICH G.J., KITA H. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J. Immunol., 1996, 156 : 4859-4866.
67. DING L., LINSLEY P.S., HUANG L.Y., GERMAIN R.N., SHEVACH E. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B-7 expression. J. Immunol., 1993, 151 : 1224-1234.
68. BUELENS C., WILLEMS F., DELVAUX A., PIÉRARD G., DELVILLE J.P., VELU T., GOLDMAN M. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral dendritic cells. Eur. J. Immunol., 1995, 25 : 2668-2672.
69. DE WAAL MALEFYT R., YSSEL H., DE VRIES J.E. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J. Immunol., 1993, 150 : 4754-4765.
70. GROUX H., BIGLER M., DE VRIES J.E., RONCAROLO M.G. Interleukin-10 induces a long term antigen-specific anergic state in human CD4+ T cells. J. Exp. Med., 1996, 184 : 19-29.
71. GÉRARD C., BRUYNS C., MARCHANT A., ABRAMOVICZ D., VANDENABEELE P., DELVAUX A., FIERS W., GOLDMAN M., VELU T. Interleukin-10 reduces the release of tumor necrosis and prevents lethality in experimental endotoxemia. J. Exp. Med., 1993, 177 : 547-550.
72. STANDIFORD T.J., STRIETER R.M., LUKACS N.W., KUNKEL S.L. Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J. Immunol., 1995, 155 : 2222-2229.
73. FLORQUIN S., AMRAOUI Z., ABRAMOVICZ D., GOLDMAN M. Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J. Immunol., 1994, 153 : 2618-2623.
74. DONCKIER V., FLAMENT V., GÉRARD C., ABRAMOVICZ D., VANDENABEELE P., WISSING M., DELVAUX A., FIERS W., LEO O., VELU T., GOLDMAN M. Interleukin-10 modulates the release of cytokines and reduces the shock syndrome induced by anti-CD3 monoclonal antibody in mice. Transplantation, 1994, 57 : 1436-1439.
75. VAN DER POLL T., MARCHANT A., BUURMAN W.A., BERMAN L.A., KEOGH C.V., LAZARUS D.D., NGUYEN L., GOLDMAN M., MOLDAWER L.L., LOWRY S.F. Endogenous IL-10 protects mice from death during septic peritonitis. J. Immunol., 1995, 155 : 5397-5401.
76. BRANDTZAEG P., OSNES L., OVSTEBO R., JOO G.B., WESTVIK A.B., KIERULF P. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay. identification of interleukin-10 as a major functional deactivator of human monocytes. J. Exp. Med., 1996, 184 : 51-60.
77. LI L., ELLIOT J.F., MOSMANN T.R. IL-10 inhibits cytokine production., vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J. Immunol., 1994, 153 : 3967-3978.
78. KÜHN R., LÖHLER J., RENNICK D., RAJEWSKY K., MÜLLER W. Interleukin-10 deficient mice develop chronic enterocolitis. Cell, 1993, 75 : 263-274.
79. SHANLEY T.P., SCHMAL H., FRIEDL H.P., JONES M.L., WARD P.A. Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. J. Immunol., 1995, 154 : 3454-3460.
80. ZUANY-AMORIM C., HALLE S., LEDUC D., DUMAREY C., HUERRE M., VARGAFTIG BB., PETROLANI M. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J. Clin. Invest., 1995, 95 : 2644-2651.
81. VAN LAETHEM J.L., MARCHANT A., DELVAUX A., GOLDMAN M., ROBBERECHT P., VELU T., DEVIÈRE J. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology, 1995, 108 : 1917-1922.
82. RONGIONE A.J., KUSSKE A.M., KWAN K., ASHLEY S.W., REBER H.A., MCFADDEN D.W. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology, 1997, 112 : 960-967.
83. BARSIG J., KUSTERS S., VOGT K., VOLK H.D., TIEGS G., WENDEL A. Lipopolysaccharide-induced interleukin-10 in mice. role of endogenous tumor necrosis factor-alpha. Eur. J. Immunol., 1995, 25 : 2888-2893.
84. VAN DER POLL T., MARCHANT A., BUURMAN W.A., BERMAN L., KEOGH C.V., LAZARUS D.D., NGUYEN L., GOLDMAN M., MOLDAWER L.L., LOWRY S.F. Endogenous IL-10 protects mice from death during septic peritonitis. J. Immunol., 1995, 155 : 5397-5401.
85. GOLOVLIOV I., SANDSTROM G., ERICSSON M., SJOSTEDT A., TARNVIK A. Cytokine expression in the liver during the early phase of murine tularemia. Infect. Immun., 1995, 63 : 534-538.
86. WAN S., LECLERC J.L., SCHMARTZ D., BARVAIS L., HUYNH C.H., DEVIERE J., DESMET J.M., VINCENT J.L. Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients. Am. Heart J., 1997, 133 : 335-339.
87. KNOLLE P., SCHLAAK J., UHRIG A., KEMPF P., MEYER ZUM BUSCHENFELDE K.H., GERKEN G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J. Hepatol., 1995, 22 : 226-229.
88. KNOLLE P.A., UHRIG A., PROTZER U., TRIPPLER M., DUCHMANN R., MEYER ZUM BUSCHENFELDE K.H., GERKEN G. Interleukin-10 expression is autoregulated at the transcriptional level in human and murine Kupffer cells. Hepatology, 1998, 27 : 93-99.
89. ISHIZAKA S., SAITO S., YOSHIKAWA M., KIMOTO M., NISHIYAMA T. IL-10 production in mouse hepatocytes augmented by TGF-beta. Cytokine, 1996, 8 : 837-843.
90. ALFREY E.J., MOST D., WANG X., LEE L.K., HOLM B., KRIEGER N.R., SIBLEY R.K., HUIE P., DAFOE D.C. Interferon-gamma and interleukin-10 messenger RNA are up-regulated after orthotopic liver transplantation in tolerant rats : evidence for cytokine-mediated immune dysregulation. Surgery, 1995, 118 : 399-404.
91. MEHROTRA P.T., DONNELLY R.P., WONG S., KANEGANE H., GEREMEW A., MOSTOWSKI H.S., FURUKE K., SIEGEL J.P., BLOOM E.T. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J. Immunol., 1998, 160 : 2637-2644.
92. WANIDWORANUN C., STROBER W. Predominent role of tumor necrosis factor-□ in human monocyte IL-10 synthesis. J. Immunol., 1993, 151 : 6853-6861.
93. PLATZER C., MEISEL C., VOGT K., PLATZER M., VOLK H.D. Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int. Immunol., 1995, 7 : 517-523.
94. VAN DER POLL T., JANSEN J., LEVI M., TEN CATE H., TEN CATE J.W., VAN DEVENTER S.J. Regulation of interleukin-10 release by tumor necrosis factor in humans and chimpanzees. J. Exp. Med., 1994, 180 : 1985-1988.
95. WANG Z.E., ZENG S., CORRY D.B., DALTON D.K., SEDER R.A., REINER S.L., LOCKSLEY R.M. Interferon-γ independent effects of interleukin-12 administered during acute or established infection due to leishmania major. Proc. Natl. Acad. Sci., 1994, 91 : 12932-12936.
96. MORRIS S.C., MADDEN K.B., ADAMOVICZ J.J., GAUSE W.C., HUBBARD B.R., GATELY M.K., FINKELMAN F.D. Effect of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol., 1994, 152 : 1047-1056.
97. DAFTARIAN P.M., KUMAR A., KRYWORUCHKO M., DIAZMITOMA F. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-□. J. Immunol., 1996, 157 : 12-20.
98. FOUQUERAY B., BOUTARD V., PHILIPPE C., KORNREICH A., MARCHANT A., PEREZ J., GOLDMAN M., BAUD L. Mesangial cell-derived IL-10 modulates mesangial cell responses to lipopolysaccharide. Am. J. Pathol., 1995, 147 : 176-182.
99. MAEDA H., KUWAHARA H., ICHIMURA Y., OHTSUKI M., KURAKATA S., SHRAISHI A. TGF-□ enhances macrophage ability to produce IL-10 in normal and tumor bearing mice. J. Immunol., 1995, 155 : 4926-4932.
100. SCHANDENÉ L., DEL PRETE G.F., COGAN E., STORDEUR P., CRUSIAUX A., KENNES B., ROMAGNANI S., GOLDMAN M. Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. J. Clin. Invest., 1996, 97 : 309-315.
101. AMAN M.J., TRETTER T., EISENBEIS I., BUG G., DECKER T., AULITZKY W.E., TILG H., HUBER C., PESCHEL C. Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes. Blood, 1996, 87 : 4731-4736.
102. MICALLEF M.J., TANIMOTO T., KOHNO K., IKEDA M., IKEGAMI H., KURIMOTO M. Augmentation of in vitro interleukin 10 production after in vivo administration of interleukin 18 is activated macrophage-dependent and is probably not involved in the antitumor effects of interleukin 18 [In Process Citation]. Anticancer Res., 1998, 18 : 4267-4274.
103. LEHMANN M.H. Recombinant human granulocyte-macrophage colony-stimulating factor triggers interleukin-10 expression in the monocytic cell line U937. Mol. Immunol., 1998, 35 : 479-485.
104. DUREZ P., ABRAMOVICZ D., GÉRARD C., VAN MECHELEN M., AMRAOUI Z., DUBOIS C., LEO O., VELU T., GOLDMAN M. In vivo induction of IL-10 by anti-CD3 mAb or bacterial LPS. differential modulation by cyclosporin A. J. Exp. Med., 1993, 177 : 551-555.
105. MENGOZZI M., FANTUZZI G., FAGGIONI R., MARCHANT A., GOLDMAN M., ORENCOLE S.F., CLARK B.D., SIRONI M., BENIGNI F., GHEZZI P. Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production in mice. Immunology, 1994, 82 : 207-210.
106. MARCHANT A., AMRAOUI Z., GUEYDAN C., BRUYNS C., LE MOINE O., VANDENABEELE P., FIERS W., BUURMAN W.A., GOLDMAN M. Methylprednisolone differentially regulates IL-10 and tumour necrosis factor (TNF) production during murine endotoxaemia. Clin. Exp. Immunol., 1996, 106 : 91-96.
107. SWAIN M.G., APPLEYARD C., WALLACE J., WONG H., LE T. Endogenous glucocorticoids released during acute toxic liver injury enhance hepatic IL-10 synthesis and release. Am. J. Physiol., 1999, 276 : G199-G205.
108. STRASSMANN G., PATILKOOTA V., FINKELMAN F.D., FONG M., KAMBAYASHI T. Evidence for the involvement of interleukin-10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E(2). J. Exp. Med., 1994, 180 : 2365-2370.
109. VAN DER POLL T., COYLE S.M., BARBOSA K., BRAXTON C.C., LOWRY S.F. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin-10 production during human endotoxemia. J. Clin. Invest., 1996, 97 : 713-719.
110. JILG S., BARSIG J., LEIST M., KUSTERS S., VOLK H.D., WENDEL A. Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock. J. Pharmacol. Exp. Ther., 1996, 278 : 421-431.
111. GANTNER F., KUSTERS S., WENDEL A., HATZELMANN A., SCHUDT C., TIEGS G. Protection from T cell-mediated murine liver failure by phosphodiesterase inhibitors. J. Pharmacol. Exp. Ther., 1997, 280 : 53-60.
112. TARAZONA R., GONZALEZ-GARCIA A., ZAMZAMI N., MARCHETTI P., FRECHIN N., GONZALO J.A., RUYZGAYO M., VANROOIJEN N., MARTINEZA C., KROEMER G. Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo. J. Immunol., 1995, 154 : 861-870.
113. IANARO A., O'DONNELL C.A., DIROSA M., LIEW F.Y. A nitric oxide inhibitor reduces inflammation, dowregulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology, 1994, 82 : 370-375.
114. TIEGS G., KÜSTERS S., KÜNSTLE G., HENTZE H., KIEMER A.K., WENDEL A. Ebselen protects mice against T cell-dependent, TNF-mediated apoptotic liver injury1 [In Process Citation]. J. Pharmacol. Exp. Ther., 1998, 287 : 1098-1104.
115. NEMETH Z.H., HASKO G., VIZI E.S. Pyrrolidine dithiocarbamate augments IL-10, inhibits TNF-alpha, MIP-1alpha, IL-12, and nitric oxide production and protects from the lethal effect of endotoxin. Shock, 1998, 10 : 49-53.
116. BOURRIE B., BOUABOULA M., BENOIT J. M., DEROCQ JM., ESCLANGON M., LE FUR G., CASELLAS P. Enhancement of endotoxin-induced interleukin-10 production by SR 31747A, a sigma ligand. Eur. J. Immunol., 1995, 25 : 2882-2887.
117. BHARDWAJ R.S., SCHWARZ A., BECHER E., MAHNKE K., ARAGANE Y., SCHWARZ T., LUGER T.A. Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J. Immunol., 1996, 156 : 2517-2521.
118. HASKO G., NEMETH Z.H., VIZI E.S., SALZMAN A.L., SZABO C. An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents ethality in endotoxemic mice. Eur. J. Pharmacol., 1998, 358 : 261-268.
119. MANDREKAR P., CATALANO D., GIROUARD L., SZABO G. Human monocyte IL-10 production is increased by acute ethanol treatment. Cytokine, 1996, 8 : 567-577.
120. GIROUARD L., MANDREKAR P., CATALANO D., SZABO G. Regulation of monocyte interleukin-12 production by acute alcohol. a role for inhibition by interleukin-10. Alcohol. Clin. Exp. Res., 1998, 22 : 211-216.
121. ZHU J., DIAB A., MUSTAFA M., LEVI M., WAHREN B., BJORK J., HEDLUND G. Linomide suppresses chronic-relapsing experimental autoimmune encephalomyelitis in DA rats [In Process Citation]. J. Neurol. Sci., 1998, 160 : 113-120.
122. TIAN W.Z., NAVIKAS V., MATUSEVICIUS D., SODERSTROM M., FREDRIKSON S., HEDLUND G., LINK H. Linomide (roquinimex) affects the balance between pro- and anti-inflammatory cytokines in vitro in multiple sclerosis. Acta Neurol. Scand., 1998, 98 : 94-101.
123. MARRIOTT J.B., WESTBY M., COOKSON S., GUCKIAN M., GOODBOURN S., MULLER G., SHIRE M.G., STIRLING D., DALGLEISH A.G. CC-3052. a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production. J. Immunol., 1998, 161 : 4236-4243.
124. CONSTANTIN G., BROCKE S., IZIKSON A., LAUDANNA C., BUTCHER E.C. Tyrphostin AG490, a tyrosine kinase inhibitor, blocks actively induced experimental autoimmune encephalomyelitis. Eur. J. Immunol., 1998, 28 : 3523-3529.
125. BOZZA M., SOARES M.B., BOZZA P.T., SATOSKAR A.R., DIACOVO T.G., BROMBACHER F., TITUS R.G., SHOEMAKER C.B., DAVID J.R. The PACAP-type I receptor agonist maxadilan from sand fly saliva protects mice against lethal endotoxemia by a mechanism partially dependent on IL-10. Eur. J. Immunol., 1998, 28 : 3120-3127.
126. CORREALE J., ARIAS M., GILMORE W. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol., 1998, 161 : 3365-3374.
127. SHREEDHAR V.K., PRIDE M.W., SUN Y., KRIPKE M.L., STRICKLAND F.M. Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes. J. Immunol., 1998, 161 : 1327-1335.
128. HOLAN V., KUFFOVA L., ZAJICOVA A., KRULOVA M., FILIPEC M., HOLLER P., JANCAREK A. Urocanic acid enhances IL-10 production in activated CD4+ T cells. J. Immunol., 1998, 161 : 3237-3241.
129. NISHIGORI C., YAROSH D., O'CONNOR A., SHREEDHAR V.K., ULLRICH S.E., COX P., KRIPKE M.I. HindIII liposomes suppress delayed-type hypersensitivity responses in vivo and induce epidermal IL-10 in vitro. J. Immunol., 1998, 161 : 2684-2691.
130. HASKO G., SZABO C., NEMETH Z.H., LENDVAI B., VIZI E.S. Modulation by dantrolene of endotoxin-induced interleukin-10, tumour necrosis factor-alpha and nitric oxide production in vivo and in vitro. Br. J. Pharmacol., 1998, 124 : 1099-1106.
131. ELENKOV I.J., WEBSTER E., PAPANICOLAOU D.A., FLEISHER T.A., CHROUSOS G.P., WILDER R.L. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J. Immunol., 1998, 161 : 2586-2593.